STATISTICS

Treatment Statistics.

U.S. data on who gets anxiety treatment, what kind, and how well it works. Citations on every number.

Reviewed by Shariq Refai, MD, MBA, FAPA

Share this

EmailXText

Most adults who meet criteria for an anxiety disorder do not receive treatment, and among those who do, only a fraction receive care that meets survey definitions for minimal adequacy. The treatments that are studied most, especially cognitive behavioral therapy, work: meta-analyses report moderate effect sizes against control conditions and remission in roughly half of patients. The gap is less about whether good care exists and more about whether people reach it.

Key numbers at a glance

36.9%
Adults with anxiety who received any treatment, past year
NCS-R
33.9%
Of treated adults, share receiving minimally adequate care
NCS-R
g = 0.56
CBT effect size vs control, anxiety disorders
Carpenter et al., 2018
~51%
Mean remission with CBT across anxiety disorders
Carpenter et al., 2018

Publishing on this topic? The national headline figures are available as copy-paste embed widgets that stay current as we update the source. Get the embed code →

Source by source

NCS-R treatment-utilization estimates

Report that about 36.9 percent of adults with any anxiety disorder received some treatment in the past year, and of those treated, about 33.9 percent received care meeting an operational definition of minimal adequacy.

Carpenter et al., 2018 meta-analysis

Pooled placebo-controlled trials of cognitive behavioral therapy for anxiety disorders and reported a Hedges' g near 0.56, a moderate effect, with mean remission near half of patients.

Dropout meta-analyses

Report meaningful attrition from psychotherapy. Estimates for generalized anxiety disorder cluster near 17 percent for individual therapy, while older broad estimates across conditions run substantially higher, underscoring how much definitions and settings matter.

What the data isn't

  • ·The any-treatment figure counts any contact, including a single visit or a prescription, so it overstates how many people received a full course of evidence-based care.
  • ·Minimal adequacy is an operational survey threshold, not a clinical judgment that the care was right for the person.
  • ·Effect sizes describe average group differences in trials with selected samples; an individual's response can be larger, smaller, or absent.
  • ·Dropout rates vary widely by disorder, therapy type, and study design, so a single headline dropout number hides a lot of spread.

Sources

Kessler et al., National Comorbidity Survey Replication (NCS-R), 2005
https://pubmed.ncbi.nlm.nih.gov/15939837/
Date accessed: 2026-06-24
Carpenter et al., CBT for anxiety disorders meta-analysis, Depression and Anxiety, 2018
https://pubmed.ncbi.nlm.nih.gov/29451967/
Date accessed: 2026-06-24
Gersh et al., dropout in psychotherapy for GAD, 2017
https://www.sciencedirect.com/science/article/abs/pii/S0887618517301780
Date accessed: 2026-06-24

How to cite

Treatment statistics, AnxietyResearch.org, drawing on National Comorbidity Survey Replication treatment-utilization estimates and Carpenter et al. (2018) meta-analysis of CBT for anxiety. Accessed 2026-06-24. https://anxietyresearch.org/statistics/treatment-statistics

Your next step in The Shrink Network

Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.

Share this

EmailXText

Your next step in The Shrink Network

You are here: AnxietyResearch, the evidence layer of The Shrink Network.

Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.

Get clinical care at shrinkMD

Want to understand more first?